. "Appendix M: Prospects for Immunizing Against Parainfluenza Viruses." New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Vaccine Development Establishing Priorities, Volume I: Diseases of Importance in the United States
Glezen, W.P. In press. Reactive airway disorders in children: role of respiratory virus infections, Clin. Chest Med.
Glezen, W.P., F.A.Loda, and F.W.Denny. 1982. Parainfluenza viruses. Pp. 441–454 in Viral Infections of Humans, 2nd Edition, A.S.Evans, ed. New York: Plenum.
Glezen W.P., A.L.Frank, L.H.Taber, M.P.Tristan, C.Vallbona, A. Paredes, and J.E.Allison. 1983. Influenza in childhood. Pediatr. Res. 17(12):1029–1032.
Glezen, W.P., A.L.Frank, L.H.Taber, and J.A.Kasel. In press. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J. Infect. Dis.
Merz, D.C., A.Scheid, and P.W.Choppin. 1980. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J. Exp. Med. 151:275–288.
National Institute of Allergy and Infectious Diseases. In press. Report of a Workshop on Respiratory Syncytial Virus and Parainfluenza Viruses. National Institutes of Health.
Parrott, R.H., A.J.Vargosko, H.W.Kim, J.A.Bellanti, and R.M. Chanock. 1962. III. Myxoviruses parainfluenza. Am. J. Public Health 52:907–917.
Portner, A. 1981. The HN glycoprotein of Sendai virus: Analysis of site(s) involved in hemagglutinating and neuraminidase activities. Virology 115:375–384.
Scheid, A., and P.W.Choppin. 1974. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai Virus. Virology 57:475–490.
Scheid, A., A.L.Caliguiri, R.W.Compans, and P.W.Choppin. 1972. Isolation of paramyxovirus glycoprotein. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology 50:640–652.
Smith, C.B., R.H.Purcell, J.A.Bellanti, and R.M.Chanock. 1966. Protective effect of antibody to parainfluenza type 1 virus. N. Engl. J. Med. 275:1145–1152.
Wigley, F.M., M.H.Fruchtman, and R.H.Waldman. 1970. Aerosol immunization of humans with inactivated parainfluenza type 2 vaccine. N. Engl. J. Med. 283:1250–1253.